FERTIN PHARMA A/S: Financial statements 2023
CVR: 25834844
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,012,566,000 and a net result of DKK -136,701,000 compared with DKK -91,376,000 the year before. That is an increase of 13.4% compared with the year before. The profit margin was -13.5%. Equity in the 2023 report amounted to DKK 458,408,000. The solvency ratio was 18.3%. The company had 654 employees in the financial year.
- Revenue
- DKK 1,012,566,000
- Gross Profit
- DKK 34,144,000
- Profit/Loss
- DKK -136,701,000
- Equity
- DKK 458,408,000
- Total Assets
- DKK 2,498,199,000
- Employees
- 654
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 1B | 34.1M | -136.7M | 458.4M | 654 |
| 2022 | 892.6M | 25.2M | -91.4M | 596.3M | 622 |
| 2021 | 932.5M | 161.4M | 37.6M | 681.4M | 569 |
| 2020 | 991.1M | 246.4M | 155.4M | 770.1M | 674 |
| 2019 | 881.6M | 190.8M | 81.3M | 778.3M | 661 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 1, 2023, Christopher Beck Lambert has joined the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Michael Henrik Thomsen has joined the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Peter Halling has left the board of directors of FERTIN PHARMA A/S.
As of November 1, 2023, Michael Henrik Thomsen is registered as adm. dir. of FERTIN PHARMA A/S.
As of November 1, 2023, Peter Halling has stepped down as adm. dir. of FERTIN PHARMA A/S.
As of October 31, 2023, Michael Henrik Thomsen has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2022. Revenue came to DKK 892,580,000, and the net result was DKK -91,376,000.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.
